Skip to main navigation Skip to search Skip to main content

Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date01/19/15 → 01/18/16

Funding

  • Prometheus Laboratories Incorporated: $6,562.50